Cancer Care In The U.S. - Publications - Faculty & Research - Harvard Business School

Filter Results: (600)

Filter Results: (600)

Show Results For

← Page 7 of 600 Results →

Sort by

Are you looking for?

→Search All HBS Web

August 30, 2022
Article

School Choice Increases Racial Segregation Even When Parents Do Not Care About Race

By: Kalinda Ukanwa, Aziza C. Jones and Broderick L. Turner Jr.

This research examines how school choice impacts school segregation. Specifically, this work demonstrates that even if parents do not take the racial demographics of schools into account, preference differences between Black and White parents for other school... View Details

Keywords: Decision Choices and Conditions; Race; Policy; Early Childhood Education; Middle School Education; Secondary Education

May 2021
Article

Value-Based Healthcare in Urology: A Collaborative Review

By: Chanan Reitblat, Paul A. Bain, Michael E. Porter, David N. Bernstein, Thomas W. Feeley, Markus Graefen, Santosh Iyer, Matthew J. Resnick, C.J. Stimson, Quoc-Dien Trinh and Boris Gershman

Context:
In response to growing concerns over rising costs and major variation in quality, improving value for patients has been proposed as a fundamentally new strategy for how healthcare should be delivered, measured, and... View Details

Keywords: Value-based Healthcare; Integrated Practice Units; Outcome Measurement; Time-Driven Activity-Based Costing; Health Care and Treatment; Value; Cost Management; Strategy; Outcome or Result; Measurement and Metrics

Find at Harvard

August 2012 (Revised December 2023)
Background Note

Note on Health Insurance Coverage, Coding, and Payment

By: Regina E. Herzlinger and Jo Ellen Slurzberg

This note explains how health care technology and service innovators receive payment from government insurers, in the U.S. and abroad, and from private insurers. It describes each of the three steps needed to obtain reimbursement: coverage, coding, and payment. It also... View Details

Keywords: Health Care Delivery; Health Care Costs; Health Insurance; Health Insurance Marketplaces; Health Care and Treatment; Cost; Insurance; Innovation and Invention; Private Sector; Public Sector; Decision Making; Information Technology; Health Industry; Insurance Industry

September 2012 (Revised May 2015)
Case

Philips-Visicu

By: Regina E. Herzlinger, Natalie Kindred and Sara M. McKinley

Would the advent of global payment models and ACOs create sufficient demand for a telemedicine offering covering the care continuum, from hospitals to the home? This was the decision facing Royal Philips Electronics (Philips), the Netherlands-based producer of... View Details

2021
Book

Global Goliaths: Multinational Corporations in the 21st Century Economy

By: C. Fritz Foley, James R. Hines Jr. and David Wessel

Globalization and multinational corporations have long seemed partners in the enterprise of economic growth: globalization-led prosperity was the goal, and giant corporations spanning the globe would help achieve it. In recent years, however, the notion that all... View Details

Keywords: Multinational Firms and Management; Globalization; Economy; Economic Growth; Equality and Inequality; Employment; Policy

Article

Treatment Of Opioid Use Disorder Among Commercially Insured U.S. Adults, 2008–17

By: Karen Shen, Eric Barrette and Leemore S. Dafny

There is abundant literature on efforts to reduce opioid prescriptions and misuse, but comparatively little on the treatment provided to people with opioid use disorder (OUD). Using claims data representing 12–15 million nonelderly adults covered through commercial... View Details

Keywords: Opioid Treatment; Medication-assisted Treatment; Substance Use Disorder; Private Insurance; Health Disorders; Health Care and Treatment; Insurance; United States

Find at Harvard

August, 2022
Article

Billing and Insurance-Related Administrative Costs: A Cross-National Analysis

By: Barak D. Richman, Robert S. Kaplan, Japees Kohli, Dennis Purcell, Mahek Shah, Igna Bonfrer, Brian Golden, Rosemary Hannam, Will Mitchell, Daniel Cehic, Garry Crispin and Kevin A. Schulman

Billing and insurance-related costs are a significant source of wasteful health care spending in Organization for Economic Cooperation and Development nations, but these administrative burdens vary across national systems. We executed a microlevel accounting of these... View Details

Keywords: Health Care Costs; Administrative Costs; Cost; Health Care and Treatment; Health Industry

Find at Harvard

Register to Read

July–August 2008
Article

Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare

By: Regina E. Herzlinger

Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School, Cambridge, MA. She received her bachelor's degree from MIT and her doctorate from the Harvard Business School The first woman to be tenured and... View Details

Keywords: Consumer-driven Health Care; Health Care and Treatment; Health Industry

Find at Harvard

Article

The Business Case for Investing in Physician Well-Being

By: Tait D. Shanafelt, Joel Goh and Christine A. Sinsky

Importance: Widespread burnout among physicians has been recognized for more than two decades. Extensive evidence indicates that physician burnout has important personal and professional consequences.
Observations: A lack of awareness regarding... View Details

Keywords: Physicians; Well-being; ROI; Health; Welfare or Wellbeing; Ethics; Investment Return; Health Industry

Find at Harvard

October 2013
Case

Pearle Vision: Clearly Different?

By: Rajiv Lal and Natalie Kindred

Ohio-based optical retailer Pearle Vision, part of the vertically integrated Italian eyewear group Luxottica, sold glasses and offered in-store eye exams. Once the largest U.S. optical retailer, Pearle Vision, with 266 corporate stores and 356 franchised stores in... View Details

Keywords: Eye Care; Competitive Advantage; Market Participation; Retail Industry; Health Industry; United States

19 Mar 2008
Research & Ideas

Finding Success in the Middle of the Market

(for economic reasons) or decide to (for lifestyle reasons) to trade down. General Motors and Ford used to control midfield in the U.S. auto market with View Details

Keywords: by John Quelch; Auto; Retail

April 2016 (Revised May 2016)
Case

Hôpital Universitaire de Mirebalais, Partners In Health in Haiti

By: Robert S. Kaplan, Bipin Mistry and Karla Bertrand

The case describes the application of Time-Driven Activity-Based Costing (TDABC) at a new tertiary hospital, operated by Partners in Health in Mirebelais, Haiti. A project team mapped the clinical processes for use in estimating the direct costs of personnel,... View Details

Keywords: Time-Driven Activity-Based Costing; Activity Based Costing and Management; Cost Accounting; Developing Countries and Economies; Health Care and Treatment; Health Industry; Haiti

March 1994 (Revised December 2014)
Case

Humana, Inc.: Managing in a Changing Industry

By: Stuart Gilson

Intensifying competition and change in the U.S. health care industry force a large integrated health-care provider to reassess its strategy of operating both hospitals and health insurance plans (HMOs). In an attempt to increase its stock price and operating... View Details

Keywords: Business Strategy; Restructuring; Change Management; Financial Management; Health Industry

05 Jun 2019
Research & Ideas

If Your Customers Don't Care What You Charge, What Should You Charge?

found, in the retail gas markets they studied, was that accounting for increased consumer inertia led to an estimated 3.3 percent post-merger price increase, compared with the... View Details

Keywords: by Kristen Senz; Energy

01 Jun 2009
Lessons from the Classroom

The Challenges of Investing in Science-Based Innovation

she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that... View Details

Keywords: by Julia Hanna; Banking; Auto; Pharmaceutical

January 2018
Article

The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial

By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp

Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details

Keywords: Affordable Care Act (ACA); Subsidies; Weight Loss; Obesity; Incentives; Behavioral Economics; Motivation and Incentives; Behavior; Health Disorders; Health Care and Treatment; Compensation and Benefits; United States

Find at Harvard

Article

Germany's Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

By: Sara Gerke, Ariel D. Stern and Timo Minssen

Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals... View Details

Keywords: COVID-19; Reimbursement; Digital Health Reforms; Health Pandemics; Health Care and Treatment; Internet and the Web; Governing Rules, Regulations, and Reforms; Germany

July 2019
Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari

The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details

Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany

Find at Harvard

Article

Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment

By: Regina E. Herzlinger and Eugene Schneller

U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture... View Details

Keywords: Health Care; COVID-19; Regulation; Health Care and Treatment; Health Pandemics; Governing Rules, Regulations, and Reforms; Investment

02 Sep 2002
Research & Ideas

Foreign Multinationals in the U.S.: A Rocky Road

European, Japanese, and U.S. scholars to discuss the experience of foreign firms in the U.S. over View Details

Keywords: by Sarah Jane Johnston & Martha Lagace

←
7
8
…
29
30
→